A pharmacotherapy review of the novel, oral antithrombotics.
Spec Care Dentist
; 37(2): 62-70, 2017 Mar.
Article
em En
| MEDLINE
| ID: mdl-27770581
ABSTRACT
Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Contexto em Saúde:
6_ODS3_enfermedades_notrasmisibles
Problema de saúde:
6_cardiovascular_diseases
/
6_venous_thromboembolic_disease
Assunto principal:
Antitrombinas
/
Assistência Odontológica para Doentes Crônicos
/
Tromboembolia Venosa
Limite:
Humans
Idioma:
En
Revista:
Spec Care Dentist
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Albânia